New equity right for trading, Prostatype Genomics AB
At the request of Prostatype Genomics AB, equity rights will be traded on First North Growth Market as from 12 August 2026.
This information is distributed at the request of the Certified Adviser, Tapper Partners AB. For further information, please call Tapper Partners AB on +46704401098.
| Security name: | Prostatype Genomics AB TO6 |
| Short name: | PROGEN TO6 |
| ISIN code: | SE0029529767 |
| Orderbook ID: | 533892 |
| Terms: | Each (1) TO6 warrant entitles the holder to subscribe for one (1) new share in the Company. The exercise price for warrants of series TO6 will be SEK 0.10 per share, corresponding to both the subscription price per share in the Rights Issue and the share's quota value. |
| Subscription period: | 2026-09-01 - 2026-09-15 |
| Last trading day: | 2026-09-11 |
This information is distributed at the request of the Certified Adviser, Tapper Partners AB. For further information, please call Tapper Partners AB on +46704401098.
Nasdaq Stockholm AB, Issuer Surveillance, dl-ilasto@nasdaq.com, +46 8 405 7280